Literature DB >> 6751630

Aberrant immunoregulatory control of B lymphocyte function in lepromatous leprosy.

W E Bullock, S Watson, K E Nelson, V Schauf, S Makonkawkeyoon, R R Jacobson.   

Abstract

The capacity of peripheral blood mononuclear (PBM) cells from patients with leprosy to generate immunoglobulin-secreting cells in response to pokeweed mitogen (PWM) was evaluated by a reverse haemolytic plaque forming cell (PFC) assay. The PFC responses of PBM cells from patients with lepromatous (Lpr) leprosy were significantly higher (P less than 0.01) than those of PBM cells from normal controls and patients with tuberculoid leprosy. Co-culture of T lymphocytes from normal donors with PBM cells from Lpr patients reduced the PFC response of these cells to the normal range. T4+-helper lymphocytes from Lpr donors did not induce supranormal responses to PWM by normal PBM cells enriched for B lymphocytes. T8+-suppressor lymphocytes from normal donors greatly reduced the response of cultures containing normal allogeneic B cells plus T4+ cells. Conversely, when T8+ cells from Lpr donors were cocultured with normal B cells plus T4+ cells, they failed to suppress the response to PWM. In summary, these studies have demonstrated abnormally high PWM-stimulated PFC responses by B lymphocytes from patients with Lpr leprosy. This aberration, in turn, is associated with a loss of regulatory function by T8+-suppressor cells in Lpr patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6751630      PMCID: PMC1536644     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  The influence of leprosy on delayed-type skin reactions and serum agglutination titers to Candida albicans. A comparative study of patients with lepromatous and tuberculoid leprosy and controls in Ethiopia.

Authors:  A A BUCK; H F HASENCLEVER
Journal:  Am J Hyg       Date:  1963-05

2.  Regulation of B cell differentiation by T cell subsets defined with monoclonal OKT4 and OKT8 antibodies in human cord blood.

Authors:  A Yachie; T Miyawaki; T Nagaoki; T Yokoi; M Mukai; N Uwadana; N Taniguchi
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

3.  Inhibition of the proliferative response of peripheral blood lymphocytes to mycobacterial or fungal antigens by co-stimulation with antigens from various mycobacterial species.

Authors:  G M Bahr; G A Rook; J L Stanford
Journal:  Immunology       Date:  1981-11       Impact factor: 7.397

4.  Increased immunoglobulin-secreting cells in the blood of patients with active systemic lupus erythematosus.

Authors:  R M Blaese; J Grayson; A D Steinberg
Journal:  Am J Med       Date:  1980-09       Impact factor: 4.965

Review 5.  Immunological phenomena in leprosy and related diseases.

Authors:  J L Turk; A D Bryceson
Journal:  Adv Immunol       Date:  1971       Impact factor: 3.543

6.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

7.  Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus.

Authors:  B Bresnihan; H E Jasin
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

8.  Effect of Mycobacterium leprae on lymphocyte proliferation: suppression of mitogen and antigen responses of human peripheral blood mononuclear cells.

Authors:  J Touw; G L Stoner; A Belehu
Journal:  Clin Exp Immunol       Date:  1980-09       Impact factor: 4.330

9.  Decreased suppressor cell activity in disseminated granulomatous infections.

Authors:  R P Artz; R R Jacobson; W E Bullock
Journal:  Clin Exp Immunol       Date:  1980-08       Impact factor: 4.330

10.  Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus.

Authors:  C Morimoto; E L Reinherz; S F Schlossman; P H Schur; J A Mills; A D Steinberg
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

View more
  17 in total

1.  Antibodies to Mycobacterium tuberculosis-specific epitopes in lepromatous leprosy.

Authors:  G Bothamley; J S Beck; W Britton; A Elsaghier; J Ivanyi
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

2.  Selective correlation of interferon-gamma, tumour necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor with immunoglobulin G1 and immunoglobulin G3 subclass antibody in leprosy.

Authors:  R Hussain; A Kifayet; M Dojki; H M Dockrell
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

3.  Natural emergence of antigen-reactive T cells in lepromatous leprosy patients during erythema nodosum leprosum.

Authors:  S Laal; L K Bhutani; I Nath
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

4.  Dominant recognition of a cross-reactive B-cell epitope in Mycobacterium leprae 10 K antigen by immunoglobulin G1 antibodies across the disease spectrum in leprosy.

Authors:  R Hussain; H M Dockrell; T J Chiang
Journal:  Immunology       Date:  1999-04       Impact factor: 7.397

5.  In vitro suppression of interleukin 2 production by Mycobacterium leprae antigen.

Authors:  S Makonkawkeyoon; W Kasinrerk
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

6.  Suppression of delayed hypersensitivity skin reactions to tuberculin by M. leprae antigens in patients with lepromatous and tuberculoid leprosy.

Authors:  U Sengupta; S Sinha; G Ramu; J Lamb; J Ivanyi
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

7.  Monocyte-derived soluble suppressor factor(s) in patients with lepromatous leprosy.

Authors:  M Sathish; L K Bhutani; A K Sharma; I Nath
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

Review 8.  Suppressor cell activity and phenotypes in the blood or tissues of patients with leprosy.

Authors:  T H Rea
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

9.  Antibody-mediated killing of suppressor T lymphocytes as a possible cause of macroglobulinemia in the tropical splenomegaly syndrome.

Authors:  W F Piessens; S L Hoffman; A A Wadee; P W Piessens; S Ratiwayanto; L Kurniawan; J R Campbell; H A Marwoto; L L Laughlin
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

10.  Relationship between intensity of infection and immunomodulation in human schistosomiasis. I. Lymphocyte subpopulations and specific antibody responses.

Authors:  H Feldmeier; G A Gastl; U Poggensee; C Kortmann; A A Daffalla; H H Peter
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.